These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The in situ characteristics of mononuclear cell infiltrates in dermal lesions of leprosy. Gupta SK; Bhutani LK; Nath I Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):297-305. PubMed ID: 6890532 [TBL] [Abstract][Full Text] [Related]
26. The lymphocyte and resistance to leprosy. Long ER Int J Lepr Other Mycobact Dis; 1968; 36(3):336-8. PubMed ID: 5749660 [No Abstract] [Full Text] [Related]
27. In vivo macrophage suppression of delayed hypersensitivity in the guinea-pig. Katayama I; Parker D; Turk JL Immunology; 1982 Dec; 47(4):709-16. PubMed ID: 6216203 [TBL] [Abstract][Full Text] [Related]
28. Transfer of cell-mediated immunity in leprosy by transfer of lymph node cells. Antia NH; Khanolkar SR Int J Lepr Other Mycobact Dis; 1974; 42(1):28-32. PubMed ID: 4472411 [No Abstract] [Full Text] [Related]
29. Immunological aspects of human leprosy. Nath I Lepr India; 1983 Oct; 55(4):752-62. PubMed ID: 6230487 [No Abstract] [Full Text] [Related]
30. Prostaglandin-dependent regulation of the in vitro proliferative response to mycobacterial antigens of peripheral blood lymphocytes from normal donors and from patients with tuberculosis or leprosy. Bahr GM; Rook GA; Stanford JL Clin Exp Immunol; 1981 Sep; 45(3):646-53. PubMed ID: 7039874 [TBL] [Abstract][Full Text] [Related]
31. Role of lymhoid cells in passie ransfer with plasma of delayed hypersensitivity in guinea pigs. Dupuy JM; Good RA J Immunol; 1970 Nov; 105(5):1111-5. PubMed ID: 5489067 [No Abstract] [Full Text] [Related]
32. [Immunological studies in human leprosy using the Stefansky bacillus of murine leprosy]. Merklen FP; Cottenot F; Potier JC Ann Med Interne (Paris); 1972; 123(8):693-702. PubMed ID: 4629866 [No Abstract] [Full Text] [Related]
33. Carrier function in anti-hapten antibody responses. V. Analysis of cellular events in the enhancement of antibody responses by the "allogeneic effect" in DNP-OVA-primed guinea pigs challenged with a heterologous DNP-conjugate. Katz DH; Paul WE; Benacerraf B J Immunol; 1971 Nov; 107(5):1319-28. PubMed ID: 4107361 [No Abstract] [Full Text] [Related]
34. Investigation of lymphocyte activation in peripheral blood in infectious diseases. Srámková L; Fortová D Z Immunitatsforsch Exp Klin Immunol; 1972 Sep; 144(2):129-39. PubMed ID: 4282934 [No Abstract] [Full Text] [Related]
35. Vole bacillus vaccine as an immunising agent in leprosy. Ghosh S; Bose R Bull Calcutta Sch Trop Med; 1965 Oct; 13(4):134-5. PubMed ID: 5882330 [No Abstract] [Full Text] [Related]
37. The immunological spectrum of leprosy. Myrvang B Ethiop Med J; 1973 Apr; 11(2):188-9. PubMed ID: 4596876 [No Abstract] [Full Text] [Related]
38. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy. Nath I; Singh R Clin Exp Immunol; 1980 Sep; 41(3):406-14. PubMed ID: 7002396 [TBL] [Abstract][Full Text] [Related]
39. [Cytoferometric study of demyelinization diseases (author's transl)]. Doutlík S; Kucera V; Vacek Z Cas Lek Cesk; 1980; 119(15-16):455-60. PubMed ID: 7397737 [No Abstract] [Full Text] [Related]
40. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Tatum AH Ann Neurol; 1993 May; 33(5):502-6. PubMed ID: 7684583 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]